Kim Larson
Zinzino Independent Partner
Vítejte! Jsem Váš nezávislý poradce, který Vás povede na Vaší cestě za zdravím.
Investor relations
Financial calendar
Zinzino Interim report Q3 2024
Zinzino Delårsrapport Q3 2024
Zinzino Bokslutskommuniké 2024
Zinzino Year-End Report 2024
Annualreport 2024
Årsredovisning 2024
Financial reports
Press releases
ZINZINO AB (PUBL): Share subscription due to directed set-off issues
čtvrtek 19. září 2024 15:30
OtevřítZINZINO AB (PUBL.): ZINZINO ACQUIRES 49% OF CYPRIOT OLIVE OIL PRODUCER CLEANTHI ALPHA-OLENIC LTD
čtvrtek 27. června 2024 11:00
OtevřítZINZINO AB (PUBL): LETTER OF INTENT TO ACQUIRE ZURVITA INCREASES DISTRIBUTION POWER IN NORTH AMERICA
pondělí 17. června 2024 11:00
OtevřítZINZINO AB (PUBL): Zinzino announces Serbia as next step in its global expansion
úterý 11. června 2024 15:30
OtevřítZINZINO AB (PUBL): Zinzino now seeks acquisitions in the US and Asia to increase distribution power
pátek 7. června 2024 12:00
OtevřítZINZINO AB (PUBL): Announcement from the annual general meeting
pondělí 27. května 2024 16:30
OtevřítZINZINO AB (PUBL): Zinzino acquires assets in Xelliss – strategic reinforcement in southern Europe and in the microalgae spirulina
neděle 12. května 2024 13:00
OtevřítZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024
pátek 26. dubna 2024 8:00
OtevřítZINZINO AB (PUBL): Zinzino and ACN, enter a strategic partnership in Europe, and in connection with it Zinzino carries out a directed new issue of B shares for SEK 10.4 million.
pondělí 29. ledna 2024 10:00
OtevřítZINZINO AB (PUBL): Zinzino changes Certified Adviser to Carnegie Investment Bank AB (publ)
čtvrtek 30. listopadu 2023 9:00
OtevřítZINZINO AB (PUBL): Zinzino announces Mexico as next step in its global expansion
pátek 22. září 2023 8:00
OtevřítZINZINO AB (PUBL): Announcement from the annual general meeting
středa 31. května 2023 16:20
OtevřítZINZINO AB (PUBL.): NOTICE TO THE ANNUAL MEETING OF ZINZINO AB ON MAY 31, 2023
úterý 2. května 2023 8:00
OtevřítZINZINO AB (PUBL): Zinzino launches Turkey as a next market on their road towards global expansion
úterý 7. března 2023 14:30
OtevřítGrowing interest in personal health and customized supplements can be a great investment case
pondělí 28. listopadu 2022 14:30
OtevřítZINZINO AB (PUBL): Share subscription due to directed offset issue
středa 26. října 2022 16:30
OtevřítZinzino announces the launch of Singapore as next step in their global expansion
čtvrtek 7. dubna 2022 11:30
OtevřítZINZINO AB (PUBL): Zinzino acquires brand portfolio with Swiss skincare and supplements
středa 6. dubna 2022 9:30
OtevřítZINZINO AB (PUBL): MEMBERS OF THE NOMINATION COMMITTEE FOR ZINZINO AB'S ANNUAL GENERAL MEETING IN 2022
čtvrtek 18. listopadu 2021 14:00
OtevřítZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion
úterý 9. listopadu 2021 11:30
OtevřítZINZINO AB (PUBL): Zinzino announces launch of Taiwan as next step in the global expansion
čtvrtek 9. září 2021 13:00
OtevřítZINZINO AB (PUBL): Zinzino announces the launch of Malaysia as next step in their global expansion
čtvrtek 3. června 2021 11:00
OtevřítZINZINO AB (PUBL): A new signature BalanceOil from the pioneers of test-based nutrition
čtvrtek 15. dubna 2021 15:00
OtevřítZINZINO AB (PUBL): Zinzino announces the launch of India as next step in their global expansion strategy
úterý 6. dubna 2021 14:00
OtevřítZINZINO AB (PUBL): Further expansions of the Zinzino global web shop
úterý 15. prosince 2020 16:15
OtevřítZINZINO AB (PUBL): ZINZINO MOVES TO THE PREMIER SEGMENT OF FIRST NORTH GROWTH MARKET
středa 16. září 2020 10:00
OtevřítZINZINO AB (PUBL): ONE-TIME EFFECT DUE TO CHANGED ACCOUNTING FOR DISTRIBUTOR REMUNERATION IMPROVES Q1 2020 WITH SEK 22.2 MILLION BEFORE TAX
úterý 5. května 2020 12:00
OtevřítZINZINO AB (PUBL): Zinzino and Life Leadership collaborate to provide test-based nutrition to expanding markets
pátek 25. října 2019 16:40
OtevřítZinzino AB (PUBL): Interim Report for the third Quarter 2018
čtvrtek 15. listopadu 2018 8:00
OtevřítZINZINO AB (PUBL): THE BOARD DECIDES TO ISSUE 200 000 STOCK OPTIONS
pondělí 15. října 2018 15:00
OtevřítZINZINO AB (PUBL): PRELIMINARY SALES REPORT SECOND QUARTER 2018
čtvrtek 5. července 2018 13:00
OtevřítZINZINO AB (PUBL.) APPOINTED “GROWTH COMPANY OF THE YEAR 2017” BY DIRECT SELLING SWEDEN
pátek 1. června 2018 11:00
OtevřítZINZINO AB (PUBL): Q1; CONTINUED SOUND GROWTH AND STRONG PROFITABILITY IMPROVEMENT, EBITDA RISING BY 45%
úterý 15. května 2018 8:00
OtevřítZINZINO LAUNCHES NEW PRODUCT: ENERGY BAR - DELICIOUS AND HEALTHY!
pondělí 12. března 2018 17:00
OtevřítZINZINO AB (PUBL): STRONG GROWTH AND PROPOSAL FOR GREATLY INCREASED DIVIDENDS
středa 28. února 2018 8:00
OtevřítZINZINO AB (PUBL): PRELIMINARY SALES REPORT FOR Q4 AND 2017 WITH PROPOSAL TO INCREASE DIVIDEND
pátek 19. ledna 2018 18:00
OtevřítInterim report, July – September 2017: IMPROVED GROSS MARGINS AND STRONG GROWTH IN THE DOMESTIC MARKET.
pondělí 13. listopadu 2017 8:30
OtevřítZinzino launches groundbreaking product: BalanceOil Vegan for the heart and brain
pátek 20. října 2017 13:00
OtevřítZINZINO AB (PUBL): CORRECTION: PRELIMINARY SALES REPORT THIRD QUARTER 2017
úterý 10. října 2017 17:00
OtevřítInterim Report, Zinzino, April – June 2017: Very strong growth of 28% and full-scale launch of a new digital platform
čtvrtek 31. srpna 2017 9:00
OtevřítZINZINO AB (PUBL): PRELIMINARY SALES REPORT SECOND QUARTER 2017
úterý 4. července 2017 12:00
OtevřítZINZINO LAUNCHES VIVA, A NEW DIETARY SUPPLEMENT PROMOTING BETTER SLEEP, REDUCING STRESS AND INCREASING WELL-BEING
pátek 30. června 2017 15:00
OtevřítZinzino AB (publ.) appointed “Growth Company of the Year 2016” in direct sales
pátek 2. června 2017 16:00
OtevřítZinzino begins selling in Switzerland ”Rich in capital and an important market”
úterý 16. května 2017 16:00
OtevřítInterim Report, January – March 2017: Zinzino continues to deliver strong growth and is well prepared for increased profitability
středa 10. května 2017 9:00
OtevřítZinzino taking the Omega-6/Omega-3 concept to new heights with water-miscible AquaX oil
čtvrtek 7. července 2016 16:24
OtevřítZinzino expands sales to all EU countries “We see a huge potential”
úterý 5. července 2016 11:10
OtevřítYear-End Report 1st January - 31st December 2015, Zinzino AB (publ)
pondělí 29. února 2016 11:53
OtevřítSweden's Zinzino is improving its foothold in Europe – with the establishment of operations in Germany
pondělí 22. února 2016 8:00
OtevřítZinzino launches Zinzino LeanShake – a nutritious meal replacement for weight control
pátek 11. prosince 2015 11:58
OtevřítInterim Report July 1 - September 30, 2015 Zinzino AB (publ)
pondělí 23. listopadu 2015 15:28
OtevřítSwedish Zinzino continues to grow internationally with its establishment in Canada
čtvrtek 17. září 2015 9:28
OtevřítZinzino AB (publ) acquires further 13.8 per cent of Faun Pharma AS – safeguarding continued research and expanded product range
pátek 6. března 2015 10:29
OtevřítFinancial Statements 1 January - 31 December 2014, Zinzino AB (publ)
pátek 27. února 2015 14:39
OtevřítThe stock
Sustainability Report
Read more about our sustainability approach, targets and 2023 performance.
Greta Billing
shares@zinzino.com
+46 73 627 17 54
Fredrik Nielsen
shares@zinzino.com
+46 (0)707 900 174
Certified Adviser
All companies whose shares are to be traded on the Nasdaq First North Premier Growth Market have a certified adviser who guides and supports the company through the listing process. Subsequently, the adviser monitors that the company complies with First North's regulations for providing information to the market and investors. Carnegie Investment Bank AB (publ) is the Certified Adviser for Zinzino AB.
Certified Adviser:
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se
Why invest in Zinzino
A clear global strategy with a growth-driven, future-proof business model
Zinzino is one of Europe’s fastest-growing direct sales companies with an aggressive global expansion strategy. The Scandinavian-based health tech company is currently operating in Europe, North America, Asia, Australia, India and Africa. The overall company strategy and business model is to achieve profitable growth in new as well as existing markets. The massive growth momentum of the past decade is expected to stay constant thanks to the stability and structure of the business model in combination with top-of-the-line digital market tools as well as continuous company acquisitions.
Help improve the health of the world
Our product concept is to give health back to the world. Our goal is to get the best out of people with enthusiasm, encouragement and a great deal of energy. We are the most customer-focused direct sales company in the world. Our most important product concept, Balance, is showing continued good growth and we currently have over 500,000 test results based on blood tests in our database. We are the company that has done the most fatty acid analyses in the world.
Product development at the leading edge
Through efficient product development in-house, the company has developed a number of new products in health in which it owns its own important intellectual property rights. The newly developed products are manufactured in our own efficient production facility which means that we have 100% quality control. Zinzino’s strategy in the coming years includes continued product development at the leading edge.
Strong market position and distribution
Zinzino has strong sales organisations in its principal markets with good relationships with its customer base. The broad product portfolio attracts new customer groups and thereby generates growth. Through an updated IT platform and logistics system, Zinzino is well equipped for the expected sales growth in the coming years.
Attractive cash flow enables increased stock dividends and gives a good direct return
Zinzino’s business has a very strong cash-generating capability. Effective management of working capital combined with investments that quickly generate revenue and marginal improvements generate a strong cash flow. Thus, dividends can be distributed in accordance with the target of at least 50 per cent of the free cash flow.
Sdílet tuto stránku
nebo zkopírovat odkaz